Enveric Biosciences, Inc.
130.9M
$2.59M
-0.10
$-36.24
No price alerts set. Add an alert to get notified!
-0.10
0.29
$-36.24
-290.40%
0.00%
0.00%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
AZTR
Azitra, Inc.
|
$0.21 | -1.44% | -0.09 | $2.27M | 0.16 |
|
HEPA
Hepion Pharmaceuticals, Inc.
|
$0.04 | -2.20% | -0.05 | $465,975 | 0.02 |
|
INDP
Indaptus Therapeutics, Inc.
|
$3.45 | -0.14% | -0.36 | $6.02M | 0.00 |
|
JSPR
Jasper Therapeutics, Inc.
|
$0.98 | -3.90% | -0.25 | $15.93M | 0.30 |
|
ONCO
Onconetix, Inc.
|
$0.74 | 0.24% | -0.17 | $2.54M | 0.00 |
|
SCNI
Scinai Immunotherapeutics Ltd.
|
$0.56 | 0.90% | -0.15 | $736,606 | 0.28 |
|
SLRX
Salarius Pharmaceuticals, Inc.
|
$0.84 | 29.23% | -0.22 | $4.92M | 0.00 |
|
SLXN
Silexion Therapeutics Ltd.
|
$1.08 | 0.89% | -0.28 | $605,561 | 0.18 |
|
SPRC
SciSparc Ltd.
|
$4.83 | 9.28% | -0.02 | $290,710 | -3.14 |
|
ZVSA
ZyVersa Therapeutics, Inc.
|
$0.21 | 0.95% | -50.67 | $1.72M | 0.00 |
* Peer stocks are selected based on market capitalization and sector
$17.84
$1.71
$10.04
276.49%
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
